For research use only. Not for therapeutic Use.
8-Cyclopentyl-1,3-dipropylxanthine (Cat No.:R000505) is a potent and selective antagonist of adenosine A1 receptors, which are widely distributed in the brain and peripheral tissues. CPX is commonly used in pharmacological research to study the physiological and pathological roles of adenosine A1 receptors. By blocking these receptors, CPX can modulate various processes such as neurotransmission, cardiovascular function, and inflammation. CPX has been investigated for its potential therapeutic applications in conditions such as epilepsy, neurodegenerative diseases, and cardiovascular disorders.
Catalog Number | R000505 |
CAS Number | 102146-07-6 |
Synonyms | 8-Cyclopentyl-3,9-dihydro-1,3-dipropyl-1H-purine-2,6-dione; DPCPX, PD 116,948 |
Molecular Formula | C16H24N4O2 |
Purity | ≥95% |
Target | Adenosine Receptor |
Solubility | Limited solubility |
Storage | Store at RT |
IUPAC Name | 8-cyclopentyl-1,3-dipropyl-7H-purine-2,6-dione |
InChI | InChI=1S/C16H24N4O2/c1-3-9-19-14-12(15(21)20(10-4-2)16(19)22)17-13(18-14)11-7-5-6-8-11/h11H,3-10H2,1-2H3,(H,17,18) |
InChIKey | FFBDFADSZUINTG-UHFFFAOYSA-N |
SMILES | CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3CCCC3 |